histidine has been researched along with tocophersolan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Chen, Q; Cheng, L; Hu, H; Hu, W; Li, G; Li, Z; Long, M; Qiao, M; Qiu, L; Tian, C; Wang, M; Zhao, X | 1 |
| Chen, D; Chen, Q; Hao, T; Hu, H; Li, Z; Mei, L; Qiao, M; Qiu, L; Zhang, J; Zhao, H; Zhao, X | 1 |
2 other study(ies) available for histidine and tocophersolan
| Article | Year |
|---|---|
Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Delayed-Action Preparations; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Histidine; Humans; Hyaluronic Acid; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Micelles; Polyethylene Glycols; Vitamin E | 2014 |
pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
Topics: Antibiotics, Antineoplastic; Doxorubicin; Drug Carriers; Drug Screening Assays, Antitumor; Female; Histidine; Humans; Hydrogen-Ion Concentration; Nanoparticles; Polyglactin 910; Vitamin E | 2015 |